TY  - GEN
AU  - Heyman,Benjamin
AU  - Rizzieri,David
AU  - Adams,David J
AU  - De Castro,Carlos
AU  - Diehl,Louis
AU  - Li,Zhiguo
AU  - Moore,Joseph
AU  - Beaven,Anne
TI  - Phase I Study of the Combination of Bendamustine, Rituximab, and Pixantrone in Patients With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma
SN  - 2152-2669
PY  - 2019///1021
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Bendamustine Hydrochloride
KW  - administration & dosage
KW  - Drug Resistance, Neoplasm
KW  - drug effects
KW  - Female
KW  - Follow-Up Studies
KW  - Humans
KW  - Isoquinolines
KW  - Lymphoma, B-Cell
KW  - drug therapy
KW  - Male
KW  - Maximum Tolerated Dose
KW  - Middle Aged
KW  - Neoplasm Recurrence, Local
KW  - Prognosis
KW  - Prospective Studies
KW  - Rituximab
KW  - Salvage Therapy
KW  - Survival Rate
N1  - Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1016/j.clml.2018.07.285
ER  -